Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer
NCT ID: NCT04319146
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
20 participants
INTERVENTIONAL
2022-01-25
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cost Efficacy Evaluation of Robot Assisted Radical Prostatectomy
NCT02784314
Robotic Laparoscopic Radical Prostatectomy
NCT00292019
Prospective Comparative Study Evaluating the Early Complications of Robot-assisted Radical Prostatectomy Performed as an Outpatient Versus an Inpatient Procedure.
NCT06822452
Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer
NCT05832736
Robotic Athermal Nerve-Sparing Radical Prostatectomy
NCT02079155
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patients concerned are men over 18 years of age (with a favourable onco-geriatric opinion if \>70 years) with localised prostate cancer who are candidates for treatment by radical prostatectomy as first-line treatment. Patients must have a BMI of less than 35 kg/m², an ASA score of less than 3 and signed consent. Patients with a history of major abdominal surgery or sleep apnea syndrome will not be eligible.
The success rate of robot-assisted radical prostatectomy on an outpatient basis is defined by the absence of admission to a conventional inpatient unit within the first 24 hours after the procedure; the admission criterion being a Chung score of \>9 (street-readiness score) or a complication during the procedure that does not allow the patient to be discharged.
Concerning post-operative follow-up, on D+1, readmissions and complications will be sought by the RAAC coordination nurse. The patient will be seen again at 1 month, during which time possible consultations and/or readmissions for events related to the operation will be sought. Urinary incontinence will be investigated by completing the ICIQ continence questionnaire and early oncological findings (PAS and histology of the surgical specimen) will be evaluated. Patient satisfaction with ambulatory surgery will be assessed using the SSQ8 questionnaire collected at this visit.
Investigators are selected on the basis of their surgical experience for this technique and must have performed a minimum of 20 personal procedures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
robot-assisted radical prostatectomy
patient with a prostate cancer will be operated with a robot-assisted method. They will be supported on an outpatient basis
robot-assisted radical prostatectomy
robot-assisted radical prostatectomy as first-line treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
robot-assisted radical prostatectomy
robot-assisted radical prostatectomy as first-line treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Older than 18 years old, if\> 70 years old, then patient having had a favorable onco-geriatric consultation (Balducci 2 and life expectancy\> 10 years)
* Patient with localized prostate cancer applying for radical prostatectomy treatment
* Patient accepting outpatient surgery
* Radical prostatectomy performed as first-line treatment
* BMI \<35
* ASA score \<3
* Accompanying person available (taxi authorized) to ensure return home
* Have quick access to a telephone line
* Patient who signed their informed consent
* Patient covered by social security or other health insurance
Exclusion Criteria
* History of pelvic radiotherapy
* History of major urogenital malformation
* Sleep apnea syndrome
* Taking the following drugs within 48 hours (Plavix®, anti-vitamin K / curative LMWH)
* Contraindication to ambulatory medical care
* Inability to understand and sign the informed consent and to complete the self-questionnaires
* Vulnerable people
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de NICE Pasteur 2
Nice, CHU de Nice, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-AOIP-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.